Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,400
Closed -$389K 1682
2024
Q3
$389K Sell
5,400
-5,400
-50% -$377K 0.01% 1529
2024
Q2
$761K Sell
10,800
-14,700
-58% -$1.13M 0.01% 1247
2024
Q1
$2.03M Buy
25,500
+17,200
+207% +$1.39M 0.02% 746
2023
Q4
$745K Buy
+8,300
New +$715K 0.01% 1242
2022
Q3
Sell
-2,600
Closed -$232K 2578
2022
Q2
$232K Buy
2,600
+600
+30% +$61.2K 0.01% 1527
2022
Q1
$239K Sell
2,000
-1,300
-39% -$173K 0.01% 1599
2021
Q4
$544K Sell
3,300
-4,600
-58% -$768K 0.02% 481
2021
Q3
$1.18M Buy
7,900
+6,300
+394% +$981K 0.03% 438
2021
Q2
$252K Buy
+1,600
New +$234K 0.01% 1121
2021
Q1
Sell
-2,000
Closed -$261K 858
2020
Q4
$261K Buy
+2,000
New +$222K 0.01% 1147
2020
Q1
Sell
-9,500
Closed -$902K 1357
2019
Q4
$902K Buy
+9,500
New +$870K 0.01% 1093
2019
Q3
Sell
-7,400
Closed -$598K 2039
2019
Q2
$598K Buy
+7,400
New +$586K 0.01% 990
2018
Q4
Sell
-21,600
Closed -$1.81M 2129
2018
Q3
$1.81M Sell
21,600
-5,000
-19% -$457K 0.01% 766
2018
Q2
$2.44M Buy
26,600
+12,000
+82% +$1.12M 0.01% 800
2018
Q1
$1.24M Buy
14,600
+11,100
+317% +$1.01M 0.01% 1144
2017
Q4
$297K Buy
+3,500
New +$333K 0.01% 1006

Other funds holding APTV

Two Sigma Securities's APTV Position: Q3 2025 in Review

Two Sigma Securities sold out of Aptiv (APTV) in Q3 2025, closing a stake of 5,322 shares — an estimated $363K sold.

Two Sigma Securities first reported a position in APTV in Q2 2016 and held it in 10 quarters. The position peaked at $647K in Q4 2021. 688 funds tracked by Wall St. Rank hold APTV as of Q3 2025.

  • Two Sigma Securities reported no remaining Aptiv position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 5,322 Aptiv shares in Q3 2025, an estimated $363K.
  • Two Sigma Securities first reported a position in Aptiv in Q2 2016 and held it in 10 quarters.
  • Two Sigma Securities's Aptiv position peaked at $647K in Q4 2021.
  • 688 funds tracked by Wall St. Rank held Aptiv as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.